The latest research study “Circulating Tumor Cells (CTC) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global circulating tumor cells (CTC) market size reached US$ 9.54 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 18.24 Billion by 2027, exhibiting a growth rate (CAGR) of 10.70% during 2022-2027.
Circulating tumor cells (CTC) refer to cancer cells that break away from the primary tumor and appear in the circulatory system as clusters or singular units. They have various biological phenotypes, such as mesenchymal, epithelial, and mixed epithelial-mesenchymal. CTC levels in the blood of a patient can allow early detection of cancer and act as a prognostic indicator. As they are in minimal quantity, several technologies are used for the enrichment, isolation, and detection of these cells, including size-based separation, immunocapture, density-based separation, and microscopy. CTC has widespread applications in cancer research, drug development, liquid biopsy, and clinical biomarkers.
Request a free sample brochure: https://www.imarcgroup.com/circulating-tumor-cells-market/requestsample
Circulating Tumor Cells (CTC) Market Trends and Drivers:
Circulating tumor cells (CTC) refer to cancer cells that break away from the primary tumor and appear in the circulatory system as clusters or singular units. They have various biological phenotypes, such as mesenchymal, epithelial, and mixed epithelial-mesenchymal. CTC levels in the blood of a patient can allow early detection of cancer and act as a prognostic indicator. As they are in minimal quantity, several technologies are used for the enrichment, isolation, and detection of these cells, including size-based separation, immunocapture, density-based separation, and microscopy. CTC has widespread applications in cancer research, drug development, liquid biopsy, and clinical biomarkers.
Click here to view detailed information with table of content: https://www.imarcgroup.com/circulating-tumor-cells-market
Circulating Tumor Cells (CTC) Market Report Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
BioFluidica Inc, Creatv MicroTech Inc., CytoLumina Technologies Corp., Fluxion Biosciences Inc., Greiner Bio-One International GmbH, Ikonisys Inc, Menarini Silicon Biosystems, Miltenyi Biotec, Qiagen N.V, Rarecells Diagnostics and Stemcell Technologies.
The report has been segmented the market into following categories:
Breakup by Technology:
- CTC Detection and Enrichment Method
- CTC Direct Detection Methods
- CTC Analysis
Breakup by Application:
- Clinical/Liquid Biopsy
- Risk Assessment
- Screening and Monitoring
- Research
- Cancer Stem Cell and Tumorigenesis Research
- Drug/Therapy Development
Breakup by Product:
- Kits and Reagents
- Blood Collection Tubes
- Devices and Systems
Breakup by Specimen:
- Blood
- Bone Marrow
- Other Body Fluids
Breakup by End User:
- Hospital and Clinics
- Research and Academic Institutes
- Diagnostic Centres
By Geography:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Also Read:
- https://www.imarcgroup.com/paints-coatings-market
- https://www.imarcgroup.com/pharmaceutical-analytical-testing-outsourcing-market
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
